谷氧还蛋白2与人类健康

谷氧还蛋白2(Glutaredoxin 2,GLRX2)是一种相对分子质量较小的氧化还原酶,属于硫氧还蛋白家族成员,以谷胱甘肽为辅基调节细胞的氧化还原内环境。在非应激条件下,GLRX2结合铁硫簇,以二聚体形式存在,可能参与铁硫簇的转运或运输;当氧化压力增加时,铁硫簇解聚,GLRX2二聚体转化为GLRX2单体,利用单巯基或双巯基机制,发挥抗氧化应激和抗细胞凋亡的功能。GLRX2与人类健康和疾病,如心血管疾病、神经退行性疾病、白内障、肿瘤细胞生长与分化和精子成熟等密切相关。因此,对GLRX2的深入研究将有助于设计针对氧化应激的药物,为治疗和预防由此产生的疾病或健康问题带来新的希望。     

谷氧还蛋白系统及其对细胞氧化还原态势的调控

细胞内氧化还原调控主要是由谷氧还蛋白系统和硫氧还蛋白系统完成。谷氧还蛋白属于硫氧还蛋白超家族,广泛分布在各种生物体内。作为一种巯基转移酶,它能够催化巯基．二硫键交换反应或者还原蛋白质谷胱甘肽二硫化物,以维持胞内的氧化还原态势。谷氧蛋白系统参与氧化胁迫、蛋白修饰、信号转导、细胞调亡和细胞分化等多种生物过程。对其体内作用靶蛋白的研究,有助于阐明谷氧还蛋白在整个细胞氧化还原网络的重要调控作用。     

植物硫氧还蛋白系统

硫氧还蛋白是一类催化二硫键氧化还原的小蛋白,它通过调控细胞中氧化还原状态发挥重要的作用。在植物中,硫氧还蛋白系统尤为复杂,参与了植物的新陈代谢、转录翻译调控、信号传导以及植物的抗逆反应等。本文主要通过对植物硫氧还蛋白分类、活性位点、结构以及3种硫氧还蛋白系统研究现状进行概述,并对植物的硫氧还蛋白及系统进行了展望,从而较为全面地综述了植物的硫氧还蛋白系统,为进一步了解硫氧还蛋白在植物体内的作用机制奠定基础,也为今后的相关研究提供参考。     

硫氧还蛋白-1(Trx1)氧化还原状态的检测

硫氧还蛋白-1(thioredoxin-1,Trx1)是一种广泛存在于生物体内的氧化还原调节蛋白,其氧化还原状态的变化是细胞内发挥氧化还原调控作用的重要过程.本文建立了Trx1氧化还原状态的检测方法—氧化还原蛋白免疫印迹法(redox Western blot),即通过碘乙酸(IAA)标记Trx1,根据蛋白所带负电荷的不同,达到分离蛋白氧化与还原状态的目的,并根据能斯特方程计算出相应的氧化还原电势.本方法是在蛋白免疫印迹(Western blot)的基础上建立的,具有低成本、易操作的特点.实验中分别采用H2O2和DTT处理样本,利用此方法检测了细胞裂解液中、细胞内及过表达Trx1氧化还原电势的变化;并检测了HEK293细胞不同生长时期Trx1的氧化还原状态.     

硫氧还蛋白的结构及在生物抗氧化中的功能

硫氧还蛋白(thioredoxin,Trx)是广泛存在于原核与真核生物体内的氧化还原调节蛋白。Trx通过对目标蛋白质进行还原,从而调节机体的氧化还原平衡。Trx与硫氧还蛋白还原酶(thioredoxin reductase,TrxR)及NADPH共同组成硫氧还蛋白系统参与众多生理过程。细胞中的活性氧是导致生物氧化胁迫的一个主要方面。Trx可以通过对细胞内被氧化的二硫键的还原来修复机体的氧化损伤,并通过这种方式防止机体衰老。同时,Trx系统可以与其它氧化还原系统如谷胱甘肽(GSH)系统协调配合,并消除体内过多的活性氧。     

硫氧还蛋白结合蛋白-2在糖和脂代谢中的作用

硫氧还蛋白结合蛋白-2(thioredoxin binding protein-2,TBP-2)属于硫氧还蛋白结合蛋白家族成员,与还原型硫氧还蛋白结合,抑制其还原活性。在生物体内,TBP-2不但参与细胞内的氧化还原调节,还具有调节细胞生长繁殖和促进细胞凋亡的作用。TBP-2在葡萄糖和脂肪代谢中的作用被广泛研究。TBP-2高表达时,胰岛细胞凋亡,与糖尿病发生相关;而TBP-2缺失,与高脂血症发病有关。本文综述了TBP-2在糖脂代谢中的作用。     

硫氧还蛋白与氧化还原反应

硫氧还蛋白是生物体调节体内氧化还原系统的一种重要蛋白质,它参与了生物体内众多的氧化还原反应,其活性位点是-Cys-Gly-Pro-Cys-,在众多的生命过程中,通过构象的改变行使其调节功能。     

硫氧还蛋白在凋亡途径中的作用机制

硫氧还蛋白（Trx）是体内广泛存在的氧化还原蛋白,其家族中两种重要的硫氧还蛋白：硫氧还蛋白1（thioredoxin1,Trx1）和硫氧还蛋白2（thioredoxin2,Trx2）都含有保守的-Cys-Gly-Pro-Cys-还原序列。由于Trx具有调节细胞生长增殖和抗凋亡的作用,因此Trx在凋亡途径中的作用机制就成为了对抗肿瘤的研究热点。     

人硫氧还蛋白cDNA的克隆、表达及其多克隆抗体制备

目的 制备硫氧还蛋白1 （thioredoxin-1,Trx-1）多克隆抗体.方法 从乳腺癌细胞系MCF-7中用RT-PCR的方法得到了Trx-1全长基因,将它克隆到原核表达载体上进行大量的表达和纯化,纯化的蛋白对新西兰大白兔进行背部多点注射,40 d后取其血清用梯度饱和硫酸铵沉淀的方法进行多克隆抗体的纯化.用ELISA和Western印迹实验测定抗体效果.结果 成功获得了Trx-1全长cDNA,通过原核表达得到了大量Trx-1蛋白,并制备了高效价的多克隆抗体.结论 此多克隆抗体对Trx-1蛋白具有良好的识别能力,可以应用于Trx-1的功能研究.     

硫氧还蛋白与神经退行性病变

神经退行性病变与胞内氧化还原失衡诱发的神经元损伤,死亡有密切关系,硫氧还原白参与维持胞内氧化还原平衡,在氧化应激中起重要的氧还调节作用,因此成为对抗神经退行性病变的重要蛋白之一。硫氧还蛋白可能通过激活某些有氧还调节功能的酶,清除自由基和调节细胞内分子通道等发挥对神经元的保护作用,对转基因动物的研究,进一步提示硫氧还蛋白在神经退行性病变的防治中可能发挥重要作用。     

A novel lncRNA BADLNCR1 inhibits bovine adipogenesis by repressing GLRX5 expression

Adipogenesis is a complex cellular process, which needs a series of molecular events, including long non‐coding RNA (lncRNA). In the present study, a novel lncRNA named BADLNCR1 was identified as a regulator during bovine adipocyte differentiation, which plays an inhibitory role in lipid droplet formation and adipogenic marker gene expression. CHIPR‐seq data demonstrated a potential competitive binding motif between BADLNCR1 and sterol regulatory element‐binding proteins 1 and 2 (SREBP1/2). Dual‐luciferase reporter assay indicated target relationship between KLF2 and BADLNCR1. Moreover, after the induction of KLF2, the expression of adipogenic gene reduced, while the expression of BADLNCR1 increased. Real‐time quantitative PCR (qPCR) showed that BADLNCR1 negatively regulated mRNA expression of GLRX5 gene, a stimulator of genes that promoted formation of lipid droplets and expression of adipogenic genes. GLRX5 could partially reverse the effect of BADLNCR1 in bovine adipocyte differentiation. Dual‐luciferase reporter assay stated that BADLNCR1 significantly reduced the enhancement of C/EBPα on promoter activity of GLRX5 gene. Furthermore, CHIP‐PCR and CHIRP‐PCR confirmed the suppressing effect of BADLNCR1 on binding of C/EBPα to GLRX5 promoter. Collectively, this study revealed the molecular mechanisms underlying the negative regulation of BADLNCR1 in bovine adipogenic differentiation.     

Postnatal exposure to chromium through mother’s milk accelerates follicular atresia in F1 offspring through increased oxidative stress and depletion of antioxidant enzymes

Hexavalent chromium, CrVI, is a heavy metal endocrine disruptor, known as a mutagen, teratogen, and a group A carcinogen. Environmental contamination with CrVI, including drinking water, has been increasing in more than 30 cities in the United States. CrVI is rapidly converted to CrIII intracellularly, and CrIII can cause DNA strand breaks and cancer or apoptosis through different mechanisms. Our previous study demonstrated that lactational exposure to chromium results in a delay or arrest in follicle development and a decrease in steroid hormone levels in F1 female rats, both of which are mitigated (partial inhibition) by vitamin C. The current study tested the hypothesis that lactational exposure to CrIII accelerates follicle atresia in F1 offspring by increasing reactive oxygen species (ROS) and decreasing cellular antioxidants. Results showed that lactational exposure to CrIII dose-dependently increased follicular atresia and decreased steroidogenesis in postnatal day 25, 45, and 65 rats. Vitamin C mitigated or inhibited the effects of CrIII at all doses. CrIII increased hydrogen peroxide and lipid hydroperoxide in plasma and ovary; decreased the antioxidant enzymes (AOXs) GPx1, GR, SOD, and catalase; and increased glutathione S-transferase in plasma and ovary. To understand the effects of CrVI on ROS and AOXs in granulosa (GC) and theca (TC) cell compartments in the ovary, ROS levels and mRNA expression of cytosolic and mitochondrial AOXs, such as SOD1, SOD2, catalase, GLRX1, GSTM1, GSTM2, GSTA4, GR, TXN1, TXN2, TXNRD2, and PRDX3, were studied in GCs and TCs and in a spontaneously immortalized granulosa cell line (SIGC). Overall, CrVI downregulated each of the AOXs; and vitamin C mitigated the effects of CrVI on these enzymes in GCs and SIGCs, but failed to mitigate CrVI effects on GSTM1, GSTM2, TXN1, and TXN2 in TCs. Thus, these data for the first time reveal that lactational exposure to CrIII accelerated follicular atresia and decreased steroidogenesis in F1 female offspring by altering the ratio of ROS and AOXs in the ovary. Vitamin C is able to protect the ovary from CrIII-induced oxidative stress and follicle atresia through protective effects on GCs rather than TCs.     

Glutaredoxin 3 promotes migration and invasion via the Notch signalling pathway in oral squamous cell carcinoma

Substantial evidence indicates that the alteration of the cellular redox status is a critical factor involved in cell growth and death and results in tumourigenesis. Cancer cells have an efficient antioxidant system to counteract the increased generation of ROS. However, whether this ability to survive high levels of ROS has an important role in the growth and metastasis of tumours is not well understood. Glutaredoxin 3 (GLRX3), also known as TXNL2, Grx3 and PICOT, maintains a low level of ROS, thus contributing to the survival and metastasis of several types of cancer. However, little is known about the role of GLRX3 and the underlying mechanisms that suppress oral squamous cell carcinoma (OSCC) progression. Here, by using immunohistochemical staining, we demonstrated that GLRX3 was overexpressed in human OSCC, and enhanced GLRX3 expression correlated with metastasis and with decreased overall patient survival. Knockdown of GLRX3 in human OSCC cell lines reduced Notch activity by reversing the epithelial–mesenchymal transition (EMT), resulting in the inhibition of in vitro migration and invasion. Importantly, knockdown of GLRX3 triggered the generation of ROS. Furthermore, N-acetyl cysteine (NAC), an ROS scavenger, enhanced the effects of GLRX3 knockdown on Notch-dependent EMT. Collectively, these findings suggested the vital roles of GLRX3 in OSCC progression through its relationship with EMT progression, and these data also suggest that a strategy of blocking ROS to enhance the activity of GLRX3 knockdown warrants further attention in the treatment of OSCC.     

Comparative linkage mapping of the Grey coat colour gene in horses

Grey horses are born coloured, turn progressively grey and often develop melanomas late in life. Grey shows an autosomal dominant inheritance and the locus has previously been mapped to horse chromosome 25 (ECA25), around the TXN gene. We have now developed eight new single nucleotide polymorphisms (SNPs) associated with genes on ECA25 using information on the linear order of genes on human chromosome 9q, as well as the human and mouse coding sequences. These SNPs were mapped in relation to the Grey locus using more than 300 progeny from matings between two Swedish Warmblood grey stallions and non-grey mares. Grey was firmly assigned to an interval with flanking markers NANS and ABCA1. This corresponds to a region of approximately 6.9 Mb on human chromosome 9q. Furthermore, no recombination was observed between Grey, TGFBR1 and TMEFF1, the last two being 1.4 Mb apart in human. There are no obvious candidate genes in this region and none of the genes has been associated with pigmentation disorders or melanoma development, suggesting that the grey phenotype is caused by a mutation in a novel gene.     

A new avian leukosis virus-based packaging cell line that uses two separate transcomplementing helper genomes.

An avian leukosis virus-based packaging cell line was constructed from the genome of the Rous-associated virus type 1. The gag, pol, and env genes were separated on two different plasmids; the packaging signal and the 3' long terminal repeat were removed. On a plasmid expressing the gag and pol genes, the env gene was replaced by the hygromycin resistance gene. The phleomycin resistance gene was inserted in the place of the gag-pol genes on a plasmid expressing the env gene. The plasmid containing the gag, pol, and Hygror genes was transfected into QT6 cells. Clones that produced high levels of p27gag were transfected with the plasmid containing the Phleor and env genes. Clones that produced high levels of env protein (as measured by an interference assay) were tested for their ability to package NeoR-expressing replication-defective vectors (TXN3'). One of the clones (Isolde) was able to transfer the Neo+ phenotype to recipient cells at a titer of 10(5) resistance focus-forming units per ml. Titers of supernatants of cells infected with Rous-associated virus type 1 prior to transfection by Neor vectors were similar. Tests for recombination events that might result in intact helper virus showed no evidence for the generation of replication-competent virus. The use of selectable genes inserted next to the viral genes to generate high-producer packaging cell lines is discussed.     

The Gene for Human Glutaredoxin (GLRX) Is Localized to Human Chromosome 5q14

Glutaredoxin is a small protein (12 kDa) catalyzing glutathione-dependent disulfide oxidoreduction reactions in a coupled system with NADPH, GSH, and glutathione reductase. A cDNA encoding the human glutaredoxin gene (HGMW-approved symbol GLRX) has recently been isolated and cloned from a human fetal spleen cDNA library. The screening of a human genomic library in Charon 4A led to the identification of three genomic clones. Using fluorescencein situhybridization to metaphase chromosomes with one genomic clone as a probe, the human glutaredoxin gene was localized to chromosomal region 5q14. This localization at chromosome 5 was in agreement with the somatic cell hybrid analysis, using DNA from a human–hamster and a human–mouse hybrid panel and using a human glutaredoxin cDNA as a probe.